TP53 and hepatocellular carcinoma: Other important carcinogenic pathways deregulated in HCC involve somatic mutations in the tumor suppressor gene TP53 [34,60]; alterations to TP53 have been found in HCC patients with viral infection (HBV) and also chemical exposure.